Non-small cell lung cancer (NSCLC)
Yoshimori, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 5): 294-297
2002
ISSN/ISBN: 0047-1852 PMID: 12101676 Document Number: 545127
Document emailed within 1 workday
Related Documents
Treat, J.; Greenberg, R.; Bratschi, J.; Gorman, G.; Meehan, L.; Friedland, D. 1994: First hints in non-small cell lung cancer (NSCLC) Leukemia 8(Suppl): S55-S58Yokoyama, A. 1999: Gemcitabine hydrochloride is a new anti-cancer agent which will be available in the patients with non-small cell lung cancer (NSCLC) in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 908-915
Schmidt, S.; Nestle, U.; Walter, K.; Licht, N.; Ukena, D.; Schnabel, K.; Kirsch, C.M. 2002: Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET NUKLEARMEDIZIN. Nuclear Medicine 41(5): 217-220
Nishimura, M.; Sugiura, T.; Urata, A.; Ota, K. 1985: Current status in the treatment of inoperable non-small cell lung cancer (NSCLC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 54-60
Pathak, A.K.; Bhutani, M.; Mohan, A.; Guleria, R.; Bal, S.; Kochupillai, V. 2004: Non small cell lung cancer (NSCLC): current status and future prospects Indian Journal of Chest Diseases and Allied Sciences 46(3): 191-203
Low, J.Sh.; Koh, W.Yao.; Yap, S.Peng.; Fong, K.Weng. 2007: Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience Annals of the Academy of Medicine Singapore 36(9): 778-783
Armand, J.P. 2000: Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27 Suppl. 2: 223-230
Clement, D.; Miron, L.; Marinca, M. 2007: Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC) Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(4): 856-863
Ratanatharathorn, V.; Jirajarus, M.; Sirachainan, E.; Sirilerttrakul, S.; Euaree, A.; Supatchaipisit, P. 1998: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer (NSCLC): a preliminary study Journal of the Medical Association of Thailand 81(10): 763-771
Liu, Y.-q.; Guo, R.-h.; Liu, L.-k.; Gao, W.; Zhu, C.-j.; Wei, J.; Shu, Y.-q. 2011: Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC) Zhonghua Zhong Liu Za Zhi 33(6): 426-430
Bianco, V.; Rozzi, A.; Tonini, G.; Santini, D.; Magnolfi, E.; Vincenzi, B.; D'Angelillo, R.; Marchei, P. 2002: Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase Ii study Anticancer Research 22(5): 3053-3056
Monnet, I.; Brienza, S.; Hugret, F.; Voisin, S.; Gastiaburu, J.; Saltiel, J.C.; Soulié, P.; Armand, J.P.; Cvitkovic, E.; de Cremoux, H. 1998: Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques European Journal of Cancer 34(7): 1124-1127
Riggi, M.; Cvitkovic, E.; de Cremoux, H.; Ruffie, P.; Monnet, I.; Voisin, S.; Villalobos, W.; Azli, N.; Saltiel, J.C. 1993: Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques) European Journal of Cancer 29a(13): 1914-1915
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7